OptiNose (Germany) Top Insiders

0OP Stock  EUR 0.38  0.01  2.70%   
OptiNose employs about 189 people. The company is managed by 22 executives with a total tenure of roughly 129 years, averaging almost 5.0 years of service per executive, having 8.59 employees per reported executive. Examination of OptiNose's management performance can provide insight into the company performance.
Peter Miller  CEO
Chief Executive Officer, Director
Ramy Mahmoud  President
President, Chief Operating Officer
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

OptiNose Management Team Effectiveness

The company has return on total asset (ROA) of (0.312) % which means that it has lost $0.312 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (10.505) %, meaning that it generated substantial loss on money invested by shareholders. OptiNose's management efficiency ratios could be used to measure how well OptiNose manages its routine affairs as well as how well it operates its assets and liabilities.

OptiNose Workforce Comparison

OptiNose is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 62,829. OptiNose adds roughly 189 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (0.97) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.76) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.76.

OptiNose Notable Stakeholders

An OptiNose stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as OptiNose often face trade-offs trying to please all of them. OptiNose's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting OptiNose's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Peter MillerChief Executive Officer, DirectorProfile
Ramy MahmoudPresident, Chief Operating OfficerProfile
Keith GoldanChief Financial OfficerProfile
Sandra HeltonIndependent DirectorProfile
Tomas HeymanDirectorProfile
Anthony KrickVP OfficerProfile
John MessinaSr AffairsProfile
Catherine OwenDirectorProfile
Jonathan NeelyVP OperationsProfile
Joshua TamaroffIndependent DirectorProfile
Joseph ScodariIndependent Chairman of the BoardProfile
Sriram VenkataramanIndependent DirectorProfile
Wilhelmus GroenhuysenIndependent DirectorProfile
Michele MBAVP CFOProfile
Robert ONeilIndependent DirectorProfile
Karen BrophyChief HRProfile
William DoyleIndependent DirectorProfile
Michael EsqChief SecProfile
Victor ClavelliChief Commercial OfficerProfile
Per MDCoFounder ASProfile
Michael MarinoChief Legal Officer and Corporate SecretaryProfile
MPH MDPres COOProfile

About OptiNose Management Performance

The success or failure of an entity such as OptiNose often depends on how effective the management is. OptiNose management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of OptiNose management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the OptiNose management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. OPTINOSE INC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 204 people.

OptiNose Workforce Analysis

Traditionally, organizations such as OptiNose use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare OptiNose within its industry.

OptiNose Manpower Efficiency

Return on OptiNose Manpower

Revenue Per Employee395K
Revenue Per Executive3.4M
Net Loss Per Employee435.4K
Net Loss Per Executive3.7M

Complementary Tools for OptiNose Stock analysis

When running OptiNose's price analysis, check to measure OptiNose's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OptiNose is operating at the current time. Most of OptiNose's value examination focuses on studying past and present price action to predict the probability of OptiNose's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OptiNose's price. Additionally, you may evaluate how the addition of OptiNose to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stocks Directory
Find actively traded stocks across global markets
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges